What is he best known for?
The fields of study he is best known for:
Philippe Kourilsky mostly deals with Molecular biology, T-cell receptor, T cell, Genetics and Immunology.
His Molecular biology research includes elements of Enhancer, Transcription factor, Gene, DNA and MHC class I.
The concepts of his T-cell receptor study are interwoven with issues in Epithelium, T lymphocyte, Receptor, Beta and Cell biology.
His T cell study combines topics in areas such as Cytotoxic T cell, Gut Epithelium, CD8 and Pathology.
His Homology and Ovalbumin study in the realm of Genetics interacts with subjects such as Repertoire.
As part of one scientific family, Philippe Kourilsky deals mainly with the area of Immunology, narrowing it down to issues related to the Cellular differentiation, and often L-selectin.
His most cited work include:
- A Direct Estimate of the Human αβ T Cell Receptor Diversity (792 citations)
- A new dominant hybrid selective marker for higher eukaryotic cells. (756 citations)
- The DNA binding subunit of NF-κB is identical to factor KBF1 and homologous to the rel oncogene product (652 citations)
What are the main themes of his work throughout his whole career to date?
Philippe Kourilsky mainly investigates Molecular biology, Immunology, Gene, Major histocompatibility complex and Antigen.
His Molecular biology study incorporates themes from Plasmid, DNA, Transfection, T-cell receptor and Cytotoxic T cell.
He has researched T-cell receptor in several fields, including Receptor, Beta, CD8 and Pathology.
His Immunology study is mostly concerned with T cell, Immune system, Natural killer T cell and Cytokine.
His Gene study is focused on Genetics in general.
His work is dedicated to discovering how Major histocompatibility complex, Peptide are connected with Epitope and other disciplines.
He most often published in these fields:
- Molecular biology (41.38%)
- Immunology (25.20%)
- Gene (21.22%)
What were the highlights of his more recent work (between 1998-2017)?
- Immunology (25.20%)
- T cell (20.95%)
- T-cell receptor (19.89%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Immunology, T cell, T-cell receptor, Molecular biology and Cytotoxic T cell.
His study explores the link between Immunology and topics such as Pathology that cross with problems in Peripheral blood.
His T cell research incorporates themes from Epitope, Splenocyte, CD8 and Gut Epithelium.
His T-cell receptor research is included under the broader classification of Genetics.
In his study, Alpha is strongly linked to Beta, which falls under the umbrella field of Molecular biology.
In his work, Adoptive cell transfer and Cellular differentiation is strongly intertwined with Cell biology, which is a subfield of Cytotoxic T cell.
Between 1998 and 2017, his most popular works were:
- A Direct Estimate of the Human αβ T Cell Receptor Diversity (792 citations)
- Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. (626 citations)
- Impact of Negative Selection on the T Cell Repertoire Reactive to a Self-Peptide: A Large Fraction of T Cell Clones Escapes Clonal Deletion (322 citations)
In his most recent research, the most cited papers focused on:
T cell, Immunology, T-cell receptor, Antigen and Immune system are his primary areas of study.
The T cell study combines topics in areas such as Pathology, Molecular biology, Flow cytometry, Cytotoxic T cell and Gut Epithelium.
He regularly links together related areas like Gene in his Molecular biology studies.
His Immunology research focuses on subjects like Cellular differentiation, which are linked to L-selectin.
His study on T-cell receptor is covered under Genetics.
His research investigates the connection between Antigen and topics such as Cytokine that intersect with issues in Peripheral blood mononuclear cell, Granuloma annulare and T lymphocyte.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
